TGTX - TG Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

TGTX is currently covered by 8 analysts with an average price target of $45.82. This is a potential upside of $10.29 (28.96%) from yesterday's end of day stock price of $35.53.

TG Therapeutics's activity chart (see below) currently has 63 price targets and 85 ratings on display. The stock rating distribution of TGTX is 83.78% BUY, 5.41% SELL and 10.81% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 71.94% with an average time for these price targets to be met of 318.67 days.

Highest price target for TGTX is $55, Lowest price target is $22, average price target is $35.6.

Most recent stock forecast was given by EDWARD WHITE from HC WAINWRIGHT on 04-Mar-2025. First documented stock forecast 22-Jul-2014.

Currently out of the existing stock ratings of TGTX, 31 are a BUY (83.78%), 2 are a SELL (5.41%), 4 are a HOLD (10.81%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$55

$17.65 (47.26%)

$55

1 months 5 days ago
(04-Mar-2025)

11/20 (55%)

$19.38 (54.41%)

302

Buy

$43

$5.65 (15.13%)

$25

4 months 15 days ago
(25-Nov-2024)

7/8 (87.5%)

$8.39 (24.24%)

198

Hold

$22

$-15.35 (-41.10%)

$20

5 months 4 days ago
(05-Nov-2024)

5/8 (62.5%)

$-3.86 (-14.93%)

147

Buy

$34

$-3.35 (-8.97%)

$29

8 months 2 days ago
(07-Aug-2024)

14/14 (100%)

$14.01 (70.09%)

304

Buy

$19

1 years 9 months 14 days ago
(26-Jun-2023)

3/4 (75%)

$11.74 (161.71%)

176

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TGTX (TG Therapeutics) average time for price targets to be met?

On average it took 318.67 days on average for the stock forecasts to be realized with a an average price target met ratio 71.94

Which analyst has the current highest performing score on TGTX (TG Therapeutics) with a proven track record?

ALETHIA YOUNG

Which analyst has the most public recommendations on TGTX (TG Therapeutics)?

Alethia Young works at CANTOR FITZGERALD and has 5 price targets and 5 ratings on TGTX

Which analyst is the currently most bullish on TGTX (TG Therapeutics)?

Matthew Kaplan with highest potential upside - $54.89

Which analyst is the currently most reserved on TGTX (TG Therapeutics)?

Alec Stranahan with lowest potential downside - -$24.71

TG Therapeutics in the News

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

TG Therapeutics, Inc. NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) — TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the American Academy of Neurology 2025 annual meeting. Links to each presentation are included below. Michael S. Weiss, Chief Executive...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?